neuroClues® raises a Series A of 10M€ to accelerate its commercialization
Brussels & Paris, March 31, 2026 – Months after receiving CE certification for its Class IIa medical device, neuroCl …
neuroClues secures CE certification for its eye-tracking technology
In summary neuroClues achieves Medical Device Regulation (MDR) certification and is now allowed to issue the CE-mark on …
NeuroClues™ (P3Lab) awarded funding from the European Commission through the prestigious EIC Accelerator Program - neuroClues
In summary p3lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The …
ISO 13485:2016 certification for design & development
In summary P3Lab, a European startup founded in 2020 is developing NeuroClues®, a medical device based on eye tracking t …
P3Lab raises 4.2 million €
In summary P3Lab, a European startup founded in 2020 by former IBA and ICM employees is developing a medical device (Neu …
